Category: Support
Thanksgiving With IBD: Reclaiming Holiday Joy One Bite at a Time
Thanksgiving with IBD doesn’t have to mean sitting on the sidelines. With thoughtful recipe modifications and smart planning strategies, you can reclaim holiday joy and create new traditions that honor both your gut health and your need for celebration.
Cannabis and Crohn’s: New Study Reveals Unexpected Risks
A new study examining over 4,000 Crohn’s patients reveals that cannabis users experienced higher rates of hospitalizations, surgeries, and disease flares. While cannabis may provide symptom relief, researchers suggest it could mask underlying disease progression, raising important questions about balancing short-term comfort with long-term health outcomes.
New Guidelines Bring Hope to Families Managing Pediatric Crohn’s
New clinical practice guidelines from the Canadian Association of Gastroenterology offer hope for families managing pediatric Crohn’s disease. These evidence-based recommendations provide a clearer roadmap for personalized treatment approaches that prioritize both effective care and quality of life for children with IBD.
Crohn’s Surgery After 60: What New Research Reveals
New European research reveals that older adults with Crohn’s disease actually experience fewer immediate surgical complications than younger patients, challenging common assumptions about age and surgery risk. While long-term considerations remain important, this data offers hope for those over 60 facing difficult treatment decisions.
When Your Body Fights Back: The Daily Reality of Living with Crohn’s
Living with Crohn’s disease means navigating daily challenges that go far beyond medical symptoms. This comprehensive guide explores the real-world impact of Crohn’s on relationships, career, and emotional well-being, while offering hope and practical insights for patients and families.
Children with IBD: A Call to Action This Awareness Month
Crohn’s and Colitis Canada’s “Childhood Interrupted” campaign puts spotlight on over 7,000 Canadian children with IBD. The initiative calls for better pediatric care, school accommodations, and psychological support as cases are projected to double by 2030.
Generic Budesonide Gets FDA Nod: More Affordable Crohn’s Relief Coming
Zydus Lifesciences has received tentative FDA approval for generic Budesonide, potentially bringing more affordable Crohn’s treatment options to patients. This development could significantly reduce medication costs for those managing mild to moderate disease.
Beyond Symptoms: The Hidden Anxiety That Haunts IBD Remission
Even during remission, many people with IBD live with persistent anxiety about future flare-ups. This fear can steal the joy from good days and impact daily decision-making, but there are ways to reclaim confidence and live more fully despite chronic uncertainty.
Hidden Gut Infections May Secretly Trigger Your Next IBD Flare
New research reveals how common bacterial gut infections like Salmonella and C. diff may secretly trigger IBD flares for up to a year after infection. This groundbreaking study of over 600,000 patients shows infection doubles flare risk, offering new insights for better IBD management.
New Hope: STELARA Seeks FDA Approval for Kids with UC
Johnson & Johnson has submitted an FDA request for STELARA approval in pediatric ulcerative colitis patients. This could become the first biologic targeting dual inflammation pathways specifically for children with UC, offering new hope for families with limited treatment options.
